510(k) Report

510(k) · Cleared

Cleared

Immage Immunochemistry System Valproic Acid (Vpa) Reagent

K981403510(k) TraditionalCleared May 8, 199821-day reviewClass II21 CFR 862.3200

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Beckman Instruments, Inc. · DKB Calibrators, Drug Mixture

Cleared on May 8, 1998 as substantially equivalent to K941615 (Abbott Laboratories, 1994) after a 21-day review. Its family tree reaches back 1 generation to 1994.

Decided
May 8, 1998
Review
21 days
Class
Class II
Product code
DKB
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K941615 (1994). No later device cites it as a predicate yet.

K941615 · Axsym Valproic Acid · Abbott Laboratories · 1994199019921994199619982000
K941615 · Axsym Valproic Acid · Abbott Laboratories · 19940
  1. Root · 1 generation backK941615 Axsym Valproic AcidAbbott Laboratories · 1994
  2. This deviceK981403 Immage Immunochemistry System Valproic Acid (Vpa) ReagentBeckman Instruments, Inc. · 1998
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K941615Axsym Valproic AcidAbbott Laboratories1994—
0 (this device)K981403Immage Immunochemistry System Valproic Acid (Vpa) ReagentBeckman Instruments, Inc.1998—
FIG. 1 — Lineage of K981403, 1994–1998Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DKB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K941615Axsym Valproic Acid
Summary page 1
…r 1 3.2 Classification Name Valproic Acid (Not classified) Calibrator (21 CFR §862.3200) Predicate Device(s): IMMAGE System TDx®** Valproic Acid Abbott* Laboratories, K941615 Valproic Acid (VPA) (VPA) inc *Abbott Laboratories, Abbott Park, IL 60064 *“*Trademark of Abbott Laboratories Description: Th…
Abbott Laboratories1994—

Also cleared against K941615: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 2 other devices also cite its predicate K941615.

How does its category compare?

All DKB devices

DKB Calibrators, Drug Mixture: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DKB

2in 2014

2009: 22011: 22012: 12014: 2
2007high 2 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DKB

Too few DKB 510(k)s in any year since 2007 to give a median.

Recalls per year · DKB

2in 2022

2009: 32011: 22012: 12022: 2
2007high 3 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DKB

1in 2017

2011: 12012: 42017: 1
2007high 4 (2012) · low 0 (2007)2025

MAUDE reports naming product code DKB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20092—30
20100—00
20112—21
20121—14
20130—00
20142—00
20150—00
20160—00
20170—01
20180—00
20190—00
20200—00
20210—00
20220—20
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The IMMAGE Immunochemistry System Valproic Acid (VPA) Reagent, when used in conjunction with Beckman IMMAGE™ Immunochemistry Systems and Beckman Drug Calibrator 1, is intended for the quantitative determination of valproic acid in human serum or plasma by rate nephelometric inhibition immunoassay.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K981403: Immage Immunochemistry System Valproic Acid (Vpa) Reagent.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K981403

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026